JJET’s IPO on STAR Market Accepted, Aims to Raise RMB 2.691 Billion for Medical Device Expansion
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai...
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai...
JJET, a Chengdu-based specialist in cardiac electrophysiology interventional therapy, has completed Series A+ and Series...